My academic career to date brings together my training in clinical oncology (radiation and medical oncology) with national and global health services research, with a particular focus on evidence-based policy implementation and impact. I have a wide skill set in research methodologies including epidemiology, demography, geographic information systems, econometrics, and qualitative methods. 

I have contributed significantly to national and international policy discussion around the affordability of cancer care and the value of new technologies in cancer medicine, which has directly influenced both WHO Cancer Drug Pricing and Benefits Taskforces, and the European Medicines Agency. In my role as the Oncology Coordinator for the UK National Prostate Cancer Audit, I led the development and delivery of the first ever national hospital outcome reporting programme for radiotherapy. As chair of the Health Economics in Radiation Oncology (HERO) group within ESTRO (European Society for Radiation Oncology), I am co-leading the value-based health care initiative.

I have experience and expertise in global health research. I have previously worked at the World Health Organisation in Geneva in the TB disease domain, and have ongoing global health projects aimed at building cancer control capacity and research capability in low and middle income countries. I am the Chief Investigator of the NIH funded ARCHERY study, the first prospective international multicentre trial across India, South Africa, Jordan and Malaysia evaluating the role of AI in radiotherapy.